Summary
Global Markets Direct’s, ‘Connexios Life Sciences Pvt. Ltd. - Product Pipeline Review - 2016’, provides an overview of the Connexios Life Sciences Pvt. Ltd.’s pharmaceutical research and development focus.
The report provides comprehensive information on the therapeutics under development by Connexios Life Sciences Pvt. Ltd., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.
Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.
Scope
- The report provides a snapshot of the pipeline therapeutic landscape of Connexios Life Sciences Pvt. Ltd.
- The report provides overview of Connexios Life Sciences Pvt. Ltd. including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses Connexios Life Sciences Pvt. Ltd.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features Connexios Life Sciences Pvt. Ltd.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects
Reasons to buy
- Evaluate Connexios Life Sciences Pvt. Ltd.’s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Connexios Life Sciences Pvt. Ltd.
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Connexios Life Sciences Pvt. Ltd.’s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
'
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Connexios Life Sciences Pvt. Ltd. Snapshot 5
Connexios Life Sciences Pvt. Ltd. Overview 5
Key Information 5
Key Facts 5
Connexios Life Sciences Pvt. Ltd. - Research and Development Overview 6
Key Therapeutic Areas 6
Connexios Life Sciences Pvt. Ltd. - Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products - Monotherapy 10
Pipeline Products - Out-Licensed Products 11
Out-Licensed Products/Combination Treatment Modalities 12
Connexios Life Sciences Pvt. Ltd. - Pipeline Products Glance 13
Connexios Life Sciences Pvt. Ltd. - Early Stage Pipeline Products 13
Preclinical Products/Combination Treatment Modalities 13
Discovery Products/Combination Treatment Modalities 14
Connexios Life Sciences Pvt. Ltd. - Unknown Stage Pipeline Products 15
Unknown Products/Combination Treatment Modalities 15
Connexios Life Sciences Pvt. Ltd. - Drug Profiles 16
CNX-011-67 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
CNX-013B2 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
CNX-1049 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
CNX-014 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
CNX-015 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
CNX-016 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
CNX-017 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
CNX-018 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
CNX-023 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
CNX-024 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
CNX-025 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
Connexios Life Sciences Pvt. Ltd. - Pipeline Analysis 28
Connexios Life Sciences Pvt. Ltd. - Pipeline Products by Target 28
Connexios Life Sciences Pvt. Ltd. - Pipeline Products by Route of Administration 29
Connexios Life Sciences Pvt. Ltd. - Pipeline Products by Molecule Type 30
Connexios Life Sciences Pvt. Ltd. - Pipeline Products by Mechanism of Action 31
Connexios Life Sciences Pvt. Ltd. - Recent Pipeline Updates 32
Connexios Life Sciences Pvt. Ltd. - Dormant Projects 33
Connexios Life Sciences Pvt. Ltd. - Locations And Subsidiaries 34
Head Office 34
Other Locations & Subsidiaries 34
Appendix 35
Methodology 35
Coverage 35
Secondary Research 35
Primary Research 35
Expert Panel Validation 35
Contact Us 35
Disclaimer 36
List of Tables
Connexios Life Sciences Pvt. Ltd., Key Information 5
Connexios Life Sciences Pvt. Ltd., Key Facts 5
Connexios Life Sciences Pvt. Ltd. - Pipeline by Indication, 2016 8
Connexios Life Sciences Pvt. Ltd. - Pipeline by Stage of Development, 2016 9
Connexios Life Sciences Pvt. Ltd. - Monotherapy Products in Pipeline, 2016 10
Connexios Life Sciences Pvt. Ltd. - Out-Licensed Products in Pipeline, 2016 11
Connexios Life Sciences Pvt. Ltd. - Out-Licensed Products/ Combination Treatment Modalities, 2016 12
Connexios Life Sciences Pvt. Ltd. - Preclinical, 2016 13
Connexios Life Sciences Pvt. Ltd. - Discovery, 2016 14
Connexios Life Sciences Pvt. Ltd. - Unknown, 2016 15
Connexios Life Sciences Pvt. Ltd. - Pipeline by Target, 2016 28
Connexios Life Sciences Pvt. Ltd. - Pipeline by Route of Administration, 2016 29
Connexios Life Sciences Pvt. Ltd. - Pipeline by Molecule Type, 2016 30
Connexios Life Sciences Pvt. Ltd. - Pipeline Products by Mechanism of Action, 2016 31
Connexios Life Sciences Pvt. Ltd. - Recent Pipeline Updates, 2016 32
Connexios Life Sciences Pvt. Ltd. - Dormant Developmental Projects,2016 33
Connexios Life Sciences Pvt. Ltd., Other Locations 34
List of Figures
Connexios Life Sciences Pvt. Ltd. - Pipeline by Indication, 2016 7
Connexios Life Sciences Pvt. Ltd. - Pipeline by Stage of Development, 2016 9
Connexios Life Sciences Pvt. Ltd. - Monotherapy Products in Pipeline, 2016 10
Connexios Life Sciences Pvt. Ltd. - Pipeline by Top 10 Target, 2016 28
Connexios Life Sciences Pvt. Ltd. - Pipeline by Route of Administration, 2016 29
Connexios Life Sciences Pvt. Ltd. - Pipeline by Molecule Type, 2016 30
Connexios Life Sciences Pvt. Ltd. - Pipeline Products by Top 10 Mechanism of Action, 2016 31
